News and Announcements
Cryptocurrency startup TravelbyBit secures $3.5 million investment from world’s biggest cryptocurrency exchange, Binance
- Published October 08, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- TravelbyBit has secured a $3.5 million investment from the world’s biggest crypto-exchange, Binance.
- TravelbyBit are hoping to work with Binance to introduce cryptocurrencies into more airports on a global scale.
- The Binance Coin will become the fourth cryptocurrency payment form used on the TravelbyBit payment platform.
Cryptocurrency startup TravelbyBit has secured a $3.5 million investment from one of the world’s biggest crypto-exchanges, Binance.
Binance has a reach of $1 billion valuation and has $10 million users globally.
The Binance Coin will become the fourth cryptocurrency payment form used on the TravelbyBit payment platform.
The two companies will work together to introduce cryptocurrencies into more airports across the world.
TravelbyBit are already trialling their platform across four airports, including Brisbane Airport, and two airlines.
This collaboration allows people to use cryptocurrencies at over 30 retail stores in the airport and book holidays.
TravelbyBit Co-Founder, Caleb Yeoh said that the investment partnership is a ‘fantastic endorsement.
About TravelbyBit
TravelbyBit is opening up Australia to digital currency tourism. We enable businesses to accept payments in cryptocurrencies like Bitcoin. We also connect crypto travellers to our growing network of merchants. We currently have over 200 stores across Australia. Our campaign -“The world’s first digital currency airport” drew global media attention including 7 News, FoxNews, Lonely Planet and Time.com.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
